Abstract We report the case of a 32 year-old male with Chondroblastic Osteosarcoma of the skull, which was imaged with both 18
F-FDG PET/CT did not demonstrate the tumour, whereas the 68
Ga-RGD PET/CT clearly depicted a left-sided frontal tumour. 68 Ga-RGD PET/CT may be a clinically useful imaging modality for early detection of recurrent osteosarcoma, considering the limitations of 18 F-FDG PET in a setting of low glycolytic activity. Gallium-arginine-glycine-aspartic acid ( 68 Ga-RGD) has become an important tool for tumour diagnosis and treatment monitoring in both preclinical and clinical studies [1, 2] . Both, integrin αvβ3 expression and glucose metabolism were believed to correlate with tumour aggressiveness and progression despite their completely different pharmacodynamic mechanisms [3, 4] . Recently, other studies have demonstrated that 18 [F]fluorodeoxyglucose ( 18 F-FDG) uptake is independent of angiogenesis and that there is no correlation between 18 F-FDG uptake and angiogenesis [5, 6] . No studies have been done with 68 Acknowledgments Ms. I Schoeman and Dr. B Mokaleng for their contributions to ensuring quality control of Ga68 radiopharmaceuticals. We thank Prof. E Raubenheimer who provided histology images on behalf of George Mukhari Academic Hospital.
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